Global Dental Biomaterials Market 2021-2025
Technavio has been monitoring the dental biomaterials market and it is poised to grow by $ 492.69 mn during 2021-2025, progressing at a CAGR of 8.41% during the forecast period. Our report on the dental biomaterials market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of dental diseases and related risk factors and the use of intraoral scanners and open architecture solutions. In addition, the increasing prevalence of dental diseases and related risk factors is anticipated to boost the growth of the market as well.
The dental biomaterials market analysis includes the product segment and geographic landscape.
Technavio's dental biomaterials market is segmented as below:
By Product
- Bone grafts
- Membranes and tissue regeneration products
By Geographic
- North America
- Europe
- Asia
- ROW
This study identifies the rise in the adoption rate of CAD/CAM technologyas one of the prime reasons driving the dental biomaterials market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on dental biomaterials market covers the following areas:
- Dental biomaterials market sizing
- Dental biomaterials market forecast
- Dental biomaterials market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dental biomaterials market vendors that include Advanced Medical Solutions Group Plc, Augma Biomaterials USA Inc., DENTSPLY SIRONA Inc., Envista Holdings Corp., Geistlich Pharma AG, Henry Schein Inc., Medtronic Plc, Straumann Holding AG, Tissue Regenix Group Plc, and Zimmer Biomet Holdings Inc. Also, the dental biomaterials market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Companies MentionedAdvanced Medical Solutions Group Plc, Augma Biomaterials USA Inc., DENTSPLY SIRONA Inc., Envista Holdings Corp., Geistlich Pharma AG, Henry Schein Inc., Medtronic Plc, Straumann Holding AG, Tissue Regenix Group Plc, Zimmer Biomet Holdings Inc.